Cargando…
NT-proBNP as a surrogate for unknown heart failure and its predictive power for peripheral artery disease outcome and phenotype
Patients with peripheral artery disease (PAD) are at high risk of excess mortality despite major improvements in multimodal pharmacotherapy for cardiovascular disease. However, little is known about co-prevalences and implications for the combination of heart failure (HF) and PAD. Thus, NT-proBNP as...
Autores principales: | Zierfuss, Bernhard, Feldscher, Anna, Höbaus, Clemens, Hannes, Antonia, Koppensteiner, Renate, Schernthaner, Gerit-Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192354/ https://www.ncbi.nlm.nih.gov/pubmed/37198240 http://dx.doi.org/10.1038/s41598-023-35073-z |
Ejemplares similares
-
Angiogenin—A Proposed Biomarker for Cardiovascular Disease—Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease
por: Höbaus, Clemens, et al.
Publicado: (2021) -
Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes
por: Zierfuss, Bernhard, et al.
Publicado: (2019) -
Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023) -
NT‐proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure
por: Schmitt, Walter, et al.
Publicado: (2021) -
Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)